You are using an outdated browser. Please upgrade your browser to improve your experience.


Ligand Summary
An anti-CTLA-4 ANTIGEN monoclonal antibody initially indicated for the treatment of certain types of metastatic MELANOMA. Its mode of actions may include blocking of CTLA-4 mediated inhibition of CYTOTOXIC T LYMPHOCYTES, allowing for more efficient destruction of target tumor cells.
Synonyms & Links
DrugCentral: 4958
LyCHI:  ipilimumab

Target Activities